Thought Leadership | Fish & Richardson

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Legal Project Management

Knowledge Management

Legal Technology Services

Patent Litigation

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Standard Essential Patents

Chancery & Corporate Governance

<p><em>Inter Partes </em>Review</p>

Post-Grant Review

<p><em>Ex Parte</em> Reexamination</p>

Supplemental Examination

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Electrical & Computer Technology

Software & Internet

Consumer Electronics

Artificial Intelligence

Digital Media & E-Commerce

Financial, Business & FinTech Services

Telecommunications

Energy & Chemicals

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Autonomous Vehicles

Thought Leadership

IP Law Essentials

Post-Grant Annual Reports

Blog | January 20, 2016

An Increased Emphasis on "Proportional Discovery"

Blog | January 20, 2016

Kirtsaeng Looks to Take Second Bite Out of the Supreme Court Apple

Blog | January 14, 2016

PTAB Designates Decision in LG Electronics v. Mondis Tech IPR as Precedential

Blog | January 13, 2016

PTAB Designates Previous Board Decision in Westlake Services v. Credit Acceptance as Precedential

Blog | January 06, 2016

MDFL allows "market approach" and damages expert to testify on technical comparability

Blog | December 28, 2015

Disparaging Trademarks Afforded First Amendment Protection

Article | December 08, 2015

Changes to PTAB's Interpretation Standard Have Many Uncertain on Post-Grant Filings

Article | December 07, 2015

Will the Trans-Pacific Partnership Derail Biologics?

Blog | December 04, 2015

EU Trademark Changes in 2016

Article | December 02, 2015

Patent Infringement at the ITC: Implications for Brand-Name Drug Companies

Article | November 18, 2015

Fed. Cir. Limits Safe Harbor for Post-Approval Conduct

Article | November 10, 2015

8 Patent Myths Debunked